Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

TSN February 2, 2026

Tyson Foods Q1 FY2026 Earnings Call - Reporting Reset Exposes Beef Losses While Chicken and Prepared Foods Drive Growth

Tyson posted a solid top line but shifted the accounting lens. Q1 sales rose 6.2% to $14.3 billion, yet first-quarter Segment Operating Income fell 12% to $811 million and adjusted EPS dropped to $0.9...

  • Tyson changed its segment metric from Adjusted Operating Income to Segment Operating Income, which excludes corporate expenses and amortization, and recast the last three fiscal years to the new format.
  • Q1 sales rose 6.2% year-over-year to $14.3 billion, driven by Beef, Prepared Foods, Chicken and Pork (sales growth calculation excludes a $150M legal contingency reserve).
  • First-quarter Segment Operating Income was $811 million, down 12% year-over-year; adjusted EPS was $0.97, down 15% (partly from a higher tax rate).
  • +12 more takeaways
DIS February 2, 2026

The Walt Disney Company First Quarter 2026 Earnings Call - Streaming turns profitable, parks and films fuel growth

Disney opened fiscal 2026 on solid footing: studios delivered a blockbuster 2025 with more than $6.5 billion at the global box office, while parks and experiences posted record quarterly revenue above...

  • Studios drove more than $6.5 billion at the global box office in calendar 2025, marking Disney's third biggest year ever and ninth year as industry leader over the past decade.
  • Disney reported 37 billion-dollar films produced by its studios out of 60 industry-wide, underscoring IP dominance; Zootopia 2 grossed about $1.7 billion and became the top-grossing animated film ever.
  • Avatar: Fire and Ash joined the billion-dollar club, and Disney plans to stream both Avatar and Zootopia titles on Disney+ between now and year end to boost engagement and first streams.
  • +11 more takeaways
RVTY February 2, 2026

Revvity Q4 2025 Earnings Call - Strong finish, conservative 2026 guide (2%-3% organic) with AI push and ACD acquisition

Revvity closed 2025 with a stronger-than-expected fourth quarter, reporting $772 million in revenue, 4% organic growth, and adjusted EPS of $1.70, which pushed full-year adjusted EPS to $5.06 on $2.86...

  • Q4 results beat on the back half: revenue $772 million, 4% organic growth, adjusted EPS $1.70; full year revenue $2.86 billion, 3% organic growth, adjusted EPS $5.06.
  • 2026 guidance is deliberately cautious, calling for 2%–3% organic growth, $2.96B–$2.99B in revenue, and $5.35–$5.45 adjusted EPS.
  • Diagnostics drove the quarter, with diagnostic organic growth of 7% in Q4; immunodiagnostics and reproductive health outperformed, while newborn screening remained a strong contributor.
  • +11 more takeaways
APTV February 2, 2026

Aptiv Q4 2025 Earnings Call - VersaGen Spin April 1 Anchors 2026 Reset, Modest Growth Amid FX, Commodity, and Memory Headwinds

Aptiv closed 2025 with record Q4 revenue of $5.2 billion and $1.86 in adjusted EPS, but the call was dominated by corporate reconfiguration and cost headwinds. Management confirmed the Electrical Dist...

  • VersaGen spin confirmed for April 1, 2026, with pro forma guidance and a planned spin dividend of approximately $1.6 billion to fund debt paydown.
  • Aptiv reported record Q4 revenue of $5.2 billion, adjusted growth of 3% year-over-year, adjusted operating income of $607 million, and EPS of $1.86.
  • Q4 operating cash flow was $818 million, with about $80 million of separation costs in the quarter and roughly $180 million year-to-date related to the upcoming spin.
  • +12 more takeaways
TWST February 2, 2026

Twist Bioscience Fiscal 2026 First Quarter Earnings Call - AI-driven DNA and protein demand lifts revenue and margins, guidance raised, Q4 Adjusted EBITDA break-even reiterated

Twist posted a solid start to Fiscal 2026, reporting $103.7 million in revenue, up 17% year over year, and a 52.0% gross margin. Management attributes the quarter's outperformance to an acceleration i...

  • Revenue of $103.7 million in Q1, up 17% year over year and roughly 5% sequentially.
  • Gross margin improved to 52.0% in Q1, about four percentage points higher than Q1 FY25; company expects to maintain above-52% full-year while prioritizing growth.
  • DNA synthesis and protein solutions (DSPS) revenue was $51.1 million, up 27% year over year, driven by AI-enabled discovery customers.
  • +12 more takeaways
FBIZ January 30, 2026

First Business Financial Services Q4 2025 Earnings Call - Double-digit EPS and deposits; margin held despite isolated CRE downgrade

First Business closed 2025 with the numbers they like to sell: EPS up 14% year over year, tangible book value per share up 14%, ROATCE north of 15%, and a 17% bump to the quarterly dividend. Core depo...

  • EPS grew 14% in 2025, beating the long-term 10% target; 10-year EPS CAGR is 12%, 20-year CAGR since IPO is 10%.
  • Board approved a 17% increase to the quarterly cash dividend, reflecting excess capital and management preference for shareholder returns via organic growth.
  • Core deposits rose 12% in Q4 year over year and versus linked quarter, driven by interest-bearing and money market accounts, offsetting runoff of higher-cost CDs and wholesale funding.
  • +12 more takeaways
CHD January 30, 2026

Church & Dwight Q4 2025 Earnings Call - Evergreen model intact, portfolio reshaped and 3%-4% organic guide powered by Touchland and Arm & Hammer initiatives

Church & Dwight closed 2025 with momentum despite a softer category backdrop. Q4 reported sales rose 3.9% with Q4 EPS $0.86 and full‑year free cash flow roughly $1.2 billion. Management highlighted su...

  • Q4 reported sales +3.9% with Q4 EPS $0.86; full‑year free cash flow approximately $1.2 billion and cash conversion above 120%.
  • Organic growth in Q4 was 0.7%; adjust out the VMS business and Q4 organic is 1.8%. Full‑year 2025 organic was 0.7% and 2.0% ex‑VMS.
  • 2026 guidance: 3%–4% organic growth, reported sales down about -1.5% to -0.5% due to portfolio exits, gross margin improvement ~100 basis points, marketing ~11% of sales, and EPS growth 5%–8%.
  • +12 more takeaways
CVCO January 30, 2026

Cavco Industries Q3 FY2026 Earnings Call - Homestar Deal Boosts Revenue and Delivers >$10M Synergies but Weighs on EPS

Cavco reported a revenue beat driven by the closing of the American Homestar acquisition, which lifted Q3 net revenue to $581 million. The quarter shows the classic hybrid picture after a deal: top-li...

  • Acquisition impact: American Homestar closed in the quarter and materially contributed to revenue, adding roughly $42 million sequentially and 343 homes in Q3.
  • Revenue and EPS: Consolidated net revenue rose to $581 million, up 11.3% year-over-year, while diluted EPS fell to $5.58 from $6.90, driven by margin, SG&A and tax changes.
  • Synergies upgraded: Management now estimates tangible, measurable synergies above $10 million annually from the Homestar deal, with about half already in run rate entering Q4.
  • +12 more takeaways
FHB January 30, 2026

First Hawaiian, Inc. Q4 2025 Earnings Call - NIM Holds, Loan Growth Backsloaded, $250M Open Buyback

First Hawaiian reported a steady quarter: net interest margin ticked up to a 3.21% exit rate, net interest income was roughly flat sequentially at $170.3 million, and profitability remained strong wit...

  • NIM and margin: Fourth quarter NIM was 3.21%, an exit NIM of 3.21% for December, up 2 basis points sequentially; full year 2026 NIM guide is a tight 3.16% to 3.18%.
  • Net interest income: NII was $170.3 million in Q4, essentially flat versus Q3 (+$1 million).
  • Loan growth: Total loans grew $183 million in Q4, annualized 5.2%; management expects full year 2026 loan growth of 3% to 4%, with growth backloaded into the second half.
  • +12 more takeaways
HITI January 30, 2026

High Tide Inc. Q4 FY2025 Earnings Call - Brick-and-mortar Powerhouse Delivers Record Revenue and EBITDA, Remaxion Is Short‑Term Drag but Long‑Term Upside

High Tide closed fiscal 2025 with a clean, loud message: the Canadian brick-and-mortar play is working. Q4 revenue hit a record CAD 164 million, adjusted EBITDA was a record CAD 12.4 million, and the ...

  • Q4 revenue reached a record CAD 164 million, up 19% year-over-year and 10% sequentially, putting annualized revenue run rate above CAD 650 million.
  • Adjusted EBITDA for Q4 was a record CAD 12.4 million, up 51% year-over-year and 17% sequentially; brick-and-mortar Adjusted EBITDA margin hit a new high of 9.4%.
  • Core brick-and-mortar remains the engine: segment revenue up 15% YoY, same-store sales +5.5%, and four consecutive quarters of margin improvement.
  • +15 more takeaways